Article
A statistical framework for assessing pharmacological response and biomarkers using uncertainty estimates
2020-05-03
Abstract excerpt
Drug high-throughput screenings across large molecular-characterised cancer cell line panels enable the discovery of biomarkers, and thereby, cancer precision medicine. The ability to experimentally generate drug response data has accelerated. However, this data is typically quantified by a summary statistic from a best-fit dose response curve, whilst neglecting the uncertainty of the curve fit and the potential v...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4249201e-07b6-5f39-a824-407b1db5d3af
- DOI
- 10.1101/2020.05.01.072983
